1-181676091-G-A

Variant summary

Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1

The NM_001205293.3(CACNA1E):​c.1055+24650G>A variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.625 in 151,742 control chromosomes in the GnomAD database, including 30,796 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

Frequency

Genomes: 𝑓 0.63 ( 30796 hom., cov: 29)

Consequence

CACNA1E
NM_001205293.3 intron

Scores

2

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: -1.59

Publications

10 publications found
Variant links:
Genes affected
CACNA1E (HGNC:1392): (calcium voltage-gated channel subunit alpha1 E) Voltage-dependent calcium channels are multisubunit complexes consisting of alpha-1, alpha-2, beta, and delta subunits in a 1:1:1:1 ratio. These channels mediate the entry of calcium ions into excitable cells, and are also involved in a variety of calcium-dependent processes, including muscle contraction, hormone or neurotransmitter release, gene expression, cell motility, cell division and cell death. This gene encodes the alpha-1E subunit of the R-type calcium channels, which belong to the 'high-voltage activated' group that maybe involved in the modulation of firing patterns of neurons important for information processing. Alternatively spliced transcript variants encoding different isoforms have been described for this gene. [provided by RefSeq, Apr 2011]
CACNA1E Gene-Disease associations (from GenCC):
  • developmental and epileptic encephalopathy, 69
    Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: Ambry Genetics, Labcorp Genetics (formerly Invitae), G2P, Illumina
  • genetic developmental and epileptic encephalopathy
    Inheritance: AD Classification: DEFINITIVE Submitted by: ClinGen
  • neurodevelopmental disorder
    Inheritance: AD Classification: MODERATE Submitted by: Ambry Genetics

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -12 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.92).
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.769 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
CACNA1ENM_001205293.3 linkc.1055+24650G>A intron_variant Intron 7 of 47 ENST00000367573.7 NP_001192222.1 Q15878-1Q59FG1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
CACNA1EENST00000367573.7 linkc.1055+24650G>A intron_variant Intron 7 of 47 1 NM_001205293.3 ENSP00000356545.2 Q15878-1
CACNA1EENST00000360108.7 linkc.1055+24650G>A intron_variant Intron 7 of 46 5 ENSP00000353222.3 F8W9Z1
CACNA1EENST00000367570.6 linkc.1055+24650G>A intron_variant Intron 7 of 46 1 ENSP00000356542.1 Q15878-3
CACNA1EENST00000621791.4 linkc.1055+24650G>A intron_variant Intron 7 of 45 1 ENSP00000481619.1 Q15878-2
CACNA1EENST00000524607.6 linkc.1490+24650G>A intron_variant Intron 9 of 11 5 ENSP00000432038.2 E9PIE8

Frequencies

GnomAD3 genomes
AF:
0.626
AC:
94880
AN:
151624
Hom.:
30793
Cov.:
29
show subpopulations
Gnomad AFR
AF:
0.448
Gnomad AMI
AF:
0.804
Gnomad AMR
AF:
0.611
Gnomad ASJ
AF:
0.733
Gnomad EAS
AF:
0.790
Gnomad SAS
AF:
0.653
Gnomad FIN
AF:
0.710
Gnomad MID
AF:
0.649
Gnomad NFE
AF:
0.702
Gnomad OTH
AF:
0.610
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome
AF:
0.625
AC:
94905
AN:
151742
Hom.:
30796
Cov.:
29
AF XY:
0.630
AC XY:
46767
AN XY:
74180
show subpopulations
African (AFR)
AF:
0.447
AC:
18484
AN:
41308
American (AMR)
AF:
0.611
AC:
9326
AN:
15268
Ashkenazi Jewish (ASJ)
AF:
0.733
AC:
2540
AN:
3466
East Asian (EAS)
AF:
0.789
AC:
4051
AN:
5132
South Asian (SAS)
AF:
0.654
AC:
3133
AN:
4794
European-Finnish (FIN)
AF:
0.710
AC:
7473
AN:
10524
Middle Eastern (MID)
AF:
0.626
AC:
184
AN:
294
European-Non Finnish (NFE)
AF:
0.702
AC:
47685
AN:
67934
Other (OTH)
AF:
0.614
AC:
1299
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.504
Heterozygous variant carriers
0
1693
3385
5078
6770
8463
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
780
1560
2340
3120
3900
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.676
Hom.:
22194
Bravo
AF:
0.609
Asia WGS
AF:
0.651
AC:
2266
AN:
3478

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.92
CADD
Benign
0.11
DANN
Benign
0.58
PhyloP100
-1.6
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs3753737; hg19: chr1-181645227; API